Baccine Israeli Company

Baccine is a pre-clinical biotechnology company bringing innovative proprietary bacteria-based cancer vaccines to provide new hope for cancer patients. The company’s innovative multi-acting approach aims to provide efficient immunotherapy treatments with increased response rates and reduced side effects via localized action. Baccine was established together with the Weizmann Institute of Science, following years of research focusing on cancer resistance mechanisms, the tumor microenvironment, and the role of bacteria in tumors.